Clinical Trial Update: Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of GLK-321 for Demodex blepharitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Demodex Blepharitis

Drugs mentioned

• GLK-321

Snippet

Sponsor: Glaukos Corporation | Conditions: Demodex Blepharitis | Phase 2 | Status: RECRUITING